Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
Launched by NORTHWESTERN UNIVERSITY · Dec 9, 2022
Trial Information
Current as of June 23, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The "Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial" is studying how to help doctors safely manage medications for older adults, especially those with dementia or memory problems. Many older patients take multiple medications, which can lead to serious issues like side effects or falls. This trial will test two different reminders (or "nudges") in electronic health records that encourage doctors to think carefully about their patients' prescriptions. Over 18 months, some clinics will use these nudges, while others will not, to see if this approach helps reduce risky medication use.
To participate in this trial, patients must be seen at specific primary care clinics, like Internal Medicine or Geriatrics, associated with Northwestern Medicine or UPMC. The trial is currently active but not recruiting new participants. During the study, doctors will share their experiences with these nudges to understand how helpful they are and if they fit well into their daily work. This research is important because it aims to improve medication safety for older adults, making healthcare safer and more effective.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Northwestern Medicine or UPMC primary care clinic: Internal Medicine, Family Medicine, or General Practice or Geriatrics
- Exclusion Criteria:
- • None
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials